BBC NEWS Americas Africa Europe Middle East South Asia Asia Pacific Arabic Spanish Russian Chinese Welsh
BBCi CATEGORIES   TV   RADIO   COMMUNICATE   WHERE I LIVE   INDEX    SEARCH 

BBC NEWS
 You are in: Health
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Background Briefings 
Medical notes 
Education 
Entertainment 
Talking Point 
In Depth 
AudioVideo 


Commonwealth Games 2002

BBC Sport

BBC Weather

SERVICES 
Tuesday, 8 January, 2002, 16:54 GMT
Parkinson's stem cell advance
stem cells
Stem cells were injected in the brains of rats
Stem cells transplanted into the brain seem to change into the type needed by Parkinson's patients.

However, a UK expert warned that there were many obstacles to be overcome before they could be used as a treatment in humans.

The experiments, carried out at Harvard Medical School in the US, only so far involve rats and mice.

Stem cells are the body's "master cells", capable of altering to form different cells with a wide variety of functions throughout the body.

Scientists want to control their development to produce supplies of cells which are missing or have been destroyed by illness.

The progressive decline of Parkinson's disease is caused by the loss of brain cells which produce a key messenger chemical called dopamine.

Developing cells

This leads to involuntary shaking and loss of muscle control.

Once these dopaminergic brain cells are lost, they do not grow back naturally.

There is some evidence that transplantation of dopamine cells taken from the brains of foetuses can provide some symptom relief, but it has been difficult to obtain sufficient quantities of these.

Now the US team has shown that small quantities of stem cells, taken from an early embryo, can develop into functioning dopamine cells.

They took embryonic stem cells from mouse embryos, then transplanted them into a part of the rat brain in which dopaminergic cell loss happens in Parkinson's disease.

These brains were tested only a few weeks later, and the researchers found their transplanted cells had changed into the dopaminergic cells.

Tumour growth

In brain scans, when the rats were given drugs which would normally make these cells produce more dopamine, the new cells responded as expected.

The new cells meant that there was a measurable improvement in motor function in the rats.

However, Dr Roger Barker, from the Cambridge Centre for Brain Repair, said that there remained significant safety concerns over the use of embryonic stem cells which at the moment meant no possibility of their use even as an experimental treatment.

In 20% of the rats in the latest experiment, the cells did not grow as desired - and instead formed a brain tumour called a teratoma.

Suicide gene

In humans, this would have a devastating effect, as many of these tumours are inoperable.

Dr Barker said: "Unless you could find a way of removing the possibility of a teratoma, there is no way this could be used in humans.

"You might have to engineer in a 'suicide gene', which you would be able to switch on if a teratoma developed so that the cells would then die."

He said: "This is an interesting study, but I don't think this will be a treatment in humans for quite some time."

The study was published in the Proceedings of the National Academy of Sciences.

See also:

02 Jan 01 | Health
Cause of brain disease found
19 Jan 01 | Health
'Drug has prolonged my life'
30 Apr 01 | Health
Stem cells 'improve rat memory'
24 Jul 01 | Health
Genetic brain disease discovered
13 Nov 01 | Health
Gene clues to Parkinson's
Internet links:


The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories